We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+14.6%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$500B
AUM Growth
+$33.8B
Cap. Flow
-$25.4B
Cap. Flow %
-5.08%
Top 10 Hldgs %
30.95%
Holding
15,795
New
1,585
Increased
6,018
Reduced
6,315
Closed
1,626

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.38B
2
NVDA icon
NVIDIA
NVDA
+$732M
3
AMZN icon
Amazon
AMZN
+$606M
4
DIS icon
Walt Disney
DIS
+$559M
5
T icon
AT&T
T
+$466M

Sector Composition

Rank Sector Weight
1 Technology 3.81%
2 Healthcare 2.95%
3 Financials 2.19%
4 Consumer Discretionary 2.15%
5 Industrials 1.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNGX icon
13376
CALL
Tango Therapeutics
TNGX
$4.7B
$4.95K ﹤0.01%
+500
New +$4.34K
FBP icon
13377
PUT
First Bancorp
FBP
$4.45B
$4.93K ﹤0.01%
300
-800
-73% -$11.8K
PPBT
13378
CALL
Purple Biotech
PPBT
$1.31M
$4.91K ﹤0.01%
32
+8
+33% +$1.77K
STXS icon
13379
PUT
Stereotaxis
STXS
$137M
$4.9K ﹤0.01%
2,800
+700
+33% +$1.13K
ICD
13380
PUT
DELISTED
Independence Contract Drilling, Inc.
ICD
$4.9K ﹤0.01%
2,000
+1,900
+1,900% +$4.89K
GANX icon
13381
CALL
Gain Therapeutics
GANX
$75.9M
$4.9K ﹤0.01%
1,500
-200
-12% -$556
FLDDW
13382
Fold Holdings Warrant
FLDDW
$1.36M
$4.9K ﹤0.01%
97,729
-3,022
-3% -$128
BNIXR
13383
DELISTED
Bannix Acquisition Corp. Right
BNIXR
$4.89K ﹤0.01%
18,104
-2,701
-13% -$682
ATRA icon
13384
CALL
Atara Biotherapeutics
ATRA
$77.2M
$4.87K ﹤0.01%
380
-30,544
-99% -$712K
BNBX
13385
DELISTED
BNB PLUS CORP
BNBX
$4.87K ﹤0.01%
+1
New +$12.9K
DCPH
13386
CALL
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$4.84K ﹤0.01%
300
-3,400
-92% -$43.4K
NGS icon
13387
PUT
Natural Gas Services Group
NGS
$471M
$4.82K ﹤0.01%
300
+200
+200% +$2.89K
VTEX icon
13388
PUT
VTEX
VTEX
$755M
$4.82K ﹤0.01%
700
-1,800
-72% -$11K
CMBM
13389
CALL
DELISTED
Cambium Networks
CMBM
$4.8K ﹤0.01%
800
-700
-47% -$3.44K
IMMP
13390
CALL
Immutep
IMMP
$58.2M
$4.8K ﹤0.01%
2,000
-600
-23% -$1.19K
NAUT icon
13391
PUT
Nautilus Biotechnolgy
NAUT
$121M
$4.78K ﹤0.01%
1,600
+1,500
+1,500% +$4.29K
TOUR
13392
Tuniu
TOUR
$55.4M
$4.76K ﹤0.01%
+701
New +$6.17K
KLRS
13393
PUT
Kalaris Therapeutics
KLRS
$98.7M
$4.76K ﹤0.01%
304
-870
-74% -$34.3K
FAZE
13394
PUT
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
$4.75K ﹤0.01%
26,400
-1,100
-4% -$204
STOK icon
13395
CALL
Stoke Therapeutics
STOK
$1.98B
$4.73K ﹤0.01%
900
-300
-25% -$1.28K
STRO icon
13396
PUT
Sutro Biopharma
STRO
$427M
$4.72K ﹤0.01%
110
KAVL
13397
DELISTED
Kaival Brands Innovations Group
KAVL
$4.68K ﹤0.01%
1,109
+125
+13% +$723
WEL.WS
13398
DELISTED
Integrated Wellness Acquisition Corp Redeemable Warrants
WEL.WS
$4.68K ﹤0.01%
133,623
-11,133
-8% -$877
EH
13399
EHang Holdings
EH
$405M
$4.67K ﹤0.01%
+278
New +$4.53K
KOMP icon
13400
PUT
State Street SPDR S&P Kensho New Economies Composite ETF
KOMP
$2.76B
$4.67K ﹤0.01%
100
-900
-90% -$36.9K

Similar funds

Citadel Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Citadel Advisors held 15,795 positions worth $500B, up 7.2% from $467B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $25.4B in Q4 2023, closing 1,626 positions and reducing 6,315 holdings. Its most notable exit was Activision Blizzard, an estimated $1.41B position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.8% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Citadel Advisors opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $129M.

  • Citadel Advisors's largest Q4 2023 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,167,658 shares worth $129M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.38B increase.
  • Citadel Advisors's biggest Q4 2023 reduction was Comcast, cutting an estimated $658M.
  • Citadel Advisors fully exited Activision Blizzard in Q4 2023, selling an estimated $1.41B.
  • Citadel Advisors's ten largest holdings make up 31% of its $500B portfolio in Q4 2023.
  • Citadel Advisors opened 1,585 new positions and closed 1,626 in Q4 2023.
  • Citadel Advisors's portfolio value rose 7.2% quarter-over-quarter to $500B.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.